Description
β-Endorphin, equine TFA is an endogenous opioid peptide, which binds at high affinity to both µ/δ opioid receptors. β-Endorphin, equine TFA has analgesic properties. Appearance:SolidIC50& Target:δ Opioid Receptor/DOR µ Opioid Receptor/MORIn Vitro:β-Endorphin, equine TFA (0, 0.6, 1.2 and 3 µM) inhibits the striatal dopamine release. MCE has not independently confirmed the accuracy of these methods. They are for reference only.In Vivo:β-Endorphin, equine TFA (2 or 20 µg/kg; i.p., once) effects the acquisition and retention in the rat. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Adult Female Wistar ratsDosage: 2Biological Activity:β-Endorphin, equine TFA is an endogenous opioid peptide, which binds at high affinity to both µ/δ opioid receptors. β-Endorphin, equine TFA has analgesic properties